14,000 Employees in Industry with Revenues of 7 Billion Swiss Francs
300+ Research Groups Focus on Biotech
NEW YORK, June 3 /PRNewswire/ -- With 148 biotech companies and 72 suppliers to the industry -- or 220 firms involved in the business -- Switzerland has the world's highest biotech density per capita, reports Mario Brossi of the foreign investment agency Location Promotion Switzerland (http://www.locationswitzerland.com). "These firms employ 14,000 people and have an annual turnover of 7 billion Swiss francs," he says. "Supporting the industry are more than 300 research groups at universities and other public institutions focusing on biotechnology."
On Wednesday, June 18th during BIO 2008 at the San Diego Convention Center, Mr. Brossi will review Switzerland's biotech strong points as a participant on the International Competitiveness Panel discussion, 2:00 - 3:30 p.m., Room 24 B-C.
Swiss Investment Credentials -- One Nation, One Biotech Cluster
"New investors pumped a record 885 million francs into Swiss biotech in 2007, up from the previous record -- 780 million in '06," Mr. Brossi says. "This vote of confidence echoes a report by The Institute of Management Development in Lausanne, which has declared Switzerland the best nation for basic research and knowledge transfer between industry and academia. More than 40 technology parks throughout the country support the increasingly important tech transfer process."
Intellectual property protection is one of Switzerland's strong suits,
Mr. Brossi says. "For example, the Swiss Federal Institute of Intellectual
Property recently addressed the issue of biotechnological innovations
concerning the extent of protection given to nucleic acid sequences. The
legislation is expected to come into force on July 1 of this year." He adds
that Switzerland is a leading research nation, ranking top in terms
|SOURCE Location Promotion Switzerland|
Copyright©2008 PR Newswire.
All rights reserved